The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history did not indicate a lot specific quality issue.The investigation determined the reported difficulties appear to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design, or labeling.E1 facility name - (b)(6) hospital.
|
It was reported that the procedure was to treat a moderately calcified and tortuous lesion in the right coronary artery.The rx xience skypoint 2.25 x 18 mm stent delivery system (sds) was advanced, but failed to cross due to the anatomy.During removal, resistance was noted with the lesion.The patient experienced no untoward effects as a result of the failure to cross and there was no reported clinically significant delay in the procedure.No additional information was provided.
|